{"id":741,"date":"2026-05-28T03:15:12","date_gmt":"2026-05-28T07:15:12","guid":{"rendered":"https:\/\/www.durhampeptides.ca\/post\/glow-vs-klow"},"modified":"2026-11-09T08:35:51","modified_gmt":"2026-11-09T13:35:51","slug":"glow-vs-klow","status":"publish","type":"post","link":"https:\/\/www.durhampeptides.ca\/fr\/post\/glow-vs-klow","title":{"rendered":"GLOW vs KLOW: Comparing Multi-Peptide Research Blends"},"content":{"rendered":"<figure><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-221\" src=\"https:\/\/www.durhampeptides.ca\/wp-content\/uploads\/2026\/10\/GLOW-BANNER-IMAGE.png\" alt=\"GLOW vs KLOW peptide blend GHK-Cu BPC-157 TB-500 KPV comparison Durham Peptides Canada\" width=\"1536\" height=\"1024\" srcset=\"https:\/\/www.durhampeptides.ca\/wp-content\/uploads\/2026\/10\/GLOW-BANNER-IMAGE.png 1536w, https:\/\/www.durhampeptides.ca\/wp-content\/uploads\/2026\/10\/GLOW-BANNER-IMAGE-300x200.webp 300w, https:\/\/www.durhampeptides.ca\/wp-content\/uploads\/2026\/10\/GLOW-BANNER-IMAGE-1024x683.webp 1024w, https:\/\/www.durhampeptides.ca\/wp-content\/uploads\/2026\/10\/GLOW-BANNER-IMAGE-768x512.webp 768w, https:\/\/www.durhampeptides.ca\/wp-content\/uploads\/2026\/10\/GLOW-BANNER-IMAGE-800x533.webp 800w\" sizes=\"(max-width: 1536px) 100vw, 1536px\" \/><\/figure>\n<p>GLOW vs KLOW peptide blend GHK-Cu BPC-157 TB-500 KPV comparison Durham Peptides Canada<\/p>\n<p>\"GLOW\" and \"KLOW\" are two of the most-searched multi-peptide blend names in skin and tissue research, and they're easy to confuse \u2014 the names differ by a single letter, and they share most of the same ingredients. The difference comes down to one additional peptide. This article explains what each blend contains, how the shared base works, and how to think about the comparison from a research perspective.<\/p>\n<p>Nothing here is medical, dosing, or therapeutic guidance.<\/p>\n<p><strong>The Shared Foundation: GHK-Cu + BPC-157 + TB-500<\/strong><\/p>\n<p>Both GLOW and KLOW are built on the same three-peptide base \u2014 a combination that pairs the leading compounds from skin research and tissue research:<\/p>\n<ul><li><u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/product-page\/ghk-cu\/\" target=\"_blank\"><strong>GHK-Cu<\/strong><\/a><\/u> \u2014 the copper tripeptide studied for collagen synthesis, skin biology, and gene-expression modulation.<\/li><li><u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/product-page\/bpc-157\/\" target=\"_blank\"><strong>BPC-157<\/strong><\/a><\/u> \u2014 studied for angiogenesis (blood-vessel formation) and tissue repair.<\/li><li><u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/product-page\/tb-500-10mg\/\" target=\"_blank\"><strong>TB-500<\/strong><\/a><\/u> \u2014 the Thymosin Beta-4 fragment studied for cell migration and tissue repair.<\/li><\/ul>\n<p>This three-way base is studied for combining the major tissue-biology mechanisms \u2014 gene expression (GHK-Cu), angiogenesis (BPC-157), and cell migration (TB-500) \u2014 in a single formulation.<\/p>\n<p><strong>What \"GLOW\" Is<\/strong><\/p>\n<p>GLOW refers to this <strong>GHK-Cu + BPC-157 + TB-500<\/strong> three-peptide blend. The name is an informal industry label. Durham Peptides supplies it as the <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/product-page\/glow-blend-ghk-cu-50-mg-bpc-157-10-mg-tb-500-10-mg-70mg\/\" target=\"_blank\">Glow Blend (GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg) \u2014 70mg<\/a><\/u> at C$160.00 \u2014 a single co-formulated vial covering all three compounds.<\/p>\n<p><strong>What \"KLOW\" Is<\/strong><\/p>\n<p>KLOW is the same GHK-Cu + BPC-157 + TB-500 base <strong>plus a fourth peptide: KPV.<\/strong> The \"K\" prefix denotes the KPV addition. KPV is a short tripeptide fragment derived from the C-terminus of alpha-MSH (alpha-melanocyte-stimulating hormone), studied primarily for <strong>inflammatory-signaling<\/strong> pathways. So the conceptual difference is straightforward:<\/p>\n<ul><li><strong>GLOW<\/strong> = GHK-Cu + BPC-157 + TB-500 (gene expression + angiogenesis + cell migration)<\/li><li><strong>KLOW<\/strong> = GHK-Cu + BPC-157 + TB-500 + <strong>KPV<\/strong> (adds an inflammatory-signaling component)<\/li><\/ul>\n<p>KLOW is studied when researchers want the GLOW base plus a dedicated inflammatory-signaling peptide in the same formulation.<\/p>\n<p><strong>Comparison at a Glance<\/strong><\/p>\n<table><tr><td><\/td><td><p>GLOW<\/p><\/td><td><p>KLOW<\/p><\/td><\/tr><tr><td><p>GHK-Cu<\/p><\/td><td><p>\u2713<\/p><\/td><td><p>\u2713<\/p><\/td><\/tr><tr><td><p>BPC-157<\/p><\/td><td><p>\u2713<\/p><\/td><td><p>\u2713<\/p><\/td><\/tr><tr><td><p>TB-500<\/p><\/td><td><p>\u2713<\/p><\/td><td><p>\u2713<\/p><\/td><\/tr><tr><td><p>KPV<\/p><\/td><td><p>\u2014<\/p><\/td><td><p>\u2713<\/p><\/td><\/tr><tr><td><p>Added emphasis<\/p><\/td><td><p>Skin + tissue<\/p><\/td><td><p>Skin + tissue + inflammatory-signaling<\/p><\/td><\/tr><tr><td><p>Peptide count<\/p><\/td><td><p>3<\/p><\/td><td><p>4<\/p><\/td><\/tr><\/table>\n<p><strong>Which the Research Calls For<\/strong><\/p>\n<p>The choice between the two blends comes down to whether a study design needs the KPV inflammatory-signaling component:<\/p>\n<ul><li><strong>GLOW<\/strong> suits research focused on the core skin-biology and tissue-biology mechanisms \u2014 the three-peptide base covers gene expression, angiogenesis, and cell migration.<\/li><li><strong>KLOW<\/strong> suits research that also wants to study an inflammatory-signaling peptide (KPV) in combination with that base.<\/li><\/ul>\n<p>For most skin and tissue research built around the GHK-Cu\/BPC-157\/TB-500 mechanisms, the GLOW base is the established formulation. Durham Peptides currently supplies the <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/product-page\/glow-blend-ghk-cu-50-mg-bpc-157-10-mg-tb-500-10-mg-70mg\/\" target=\"_blank\">Glow Blend<\/a><\/u>; researchers whose study design specifically requires the KPV component would need to source KPV separately to build out the KLOW combination.<\/p>\n<p><strong>Why the GLOW Base Is So Widely Studied<\/strong><\/p>\n<p>The three-peptide GLOW base is popular in research precisely because its components are mechanistically complementary rather than redundant \u2014 each addresses a different requirement of tissue repair and skin biology. Combining them in one vial also simplifies a multi-peptide study design: one reconstitution, one storage item, consistent proportions. For the individual mechanisms, see <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/ghk-cu-skin-hair-research\/\" target=\"_blank\">GHK-Cu for Skin and Hair Research<\/a><\/u>, <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/what-is-bpc-157\/\" target=\"_blank\">What Is BPC-157?<\/a><\/u>, et <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/what-is-tb-500\/\" target=\"_blank\">What Is TB-500?<\/a><\/u>; for the blend-versus-individual question, see <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/ghk-cu-vs-glow-blend\/\" target=\"_blank\">GHK-Cu vs GLOW Blend<\/a><\/u>.<\/p>\n<p><strong>Questions fr\u00e9quentes<\/strong><\/p>\n<p><strong>What's the difference between GLOW and KLOW?<\/strong> Both share a GHK-Cu + BPC-157 + TB-500 base. KLOW adds a fourth peptide, KPV (an inflammatory-signaling tripeptide). GLOW is the three-peptide blend; KLOW is the four-peptide version.<\/p>\n<p><strong>What does KLOW stand for?<\/strong> The \"K\" denotes KPV, added to the GLOW base (GHK-Cu, BPC-157, TB-500). KLOW = KPV + the GLOW three.<\/p>\n<p><strong>What is KPV?<\/strong> A short tripeptide fragment derived from alpha-MSH, studied primarily for inflammatory-signaling pathways.<\/p>\n<p><strong>Does Durham Peptides sell GLOW or KLOW?<\/strong> Durham Peptides supplies the <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/product-page\/glow-blend-ghk-cu-50-mg-bpc-157-10-mg-tb-500-10-mg-70mg\/\" target=\"_blank\">Glow Blend<\/a><\/u> (GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg). A KLOW formulation would additionally require KPV, which would be sourced separately.<\/p>\n<p><strong>What is the GLOW blend studied for?<\/strong> The combined skin-biology and tissue-biology mechanisms of its three components \u2014 gene expression (GHK-Cu), angiogenesis (BPC-157), and cell migration (TB-500).<\/p>\n<p><strong>Which blend should I choose?<\/strong> GLOW for the core skin + tissue mechanisms; KLOW if your study design also requires the KPV inflammatory-signaling component.<\/p>\n<p><strong>Final Thoughts<\/strong><\/p>\n<p>GLOW and KLOW are the same skin-and-tissue foundation \u2014 GHK-Cu, BPC-157, and TB-500 \u2014 distinguished by KLOW's added KPV inflammatory-signaling peptide. For research built around the core three mechanisms, the GLOW blend is the established, convenient single-vial formulation; KLOW extends it for study designs that also want to study KPV. Durham Peptides supplies the <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/product-page\/glow-blend-ghk-cu-50-mg-bpc-157-10-mg-tb-500-10-mg-70mg\/\" target=\"_blank\">Glow Blend<\/a><\/u> at C$160.00.<\/p>\n<p>For the copper-peptide component, see <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/post\/ghk-cu-skin-hair-research\/\" target=\"_blank\">GHK-Cu for Skin and Hair Research<\/a><\/u>. Browse the <u><a href=\"https:\/\/www.durhampeptides.ca\/fr\/category\/all-products\/\" target=\"_blank\">full catalog<\/a><\/u>.<\/p>\n<p><strong>Selected Research References<\/strong><\/p>\n<ol><li>Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide. <em>International Journal of Molecular Sciences<\/em>. 2018;19(7):1987. <u><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29986520\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/29986520\/<\/a><\/u><\/li><li>Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al. PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation. <em>Gastroenterology<\/em>. 2008;134(1):166-178. <u><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18061177\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/18061177\/<\/a><\/u><\/li><li>Goldstein AL, Hannappel E, Kleinman HK. Thymosin Beta-4: Actin-Sequestering Protein Moonlights to Repair Injured Tissues. <em>Trends in Molecular Medicine<\/em>. 2005;11(9):421-429. <u><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16099219\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/16099219\/<\/a><\/u><\/li><\/ol>\n<p><em>All products sold by Durham Peptides are for research and laboratory use only. They are not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease.<\/em><\/p>","protected":false},"excerpt":{"rendered":"GLOW vs KLOW peptide blend GHK-Cu BPC-157 TB-500 KPV comparison Durham Peptides Canada \"GLOW\" and \"KLOW\" are two of the most-searched multi-peptide blend names in skin and tissue research, and they're easy to confuse \u2014 the names differ by a single letter, and they share most of the same ingredients. The difference comes down to one additional peptide. This article explains what each blend contains, how the shared base works, and how to think about the comparison from a research perspective....","protected":false},"author":1,"featured_media":221,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55],"tags":[],"class_list":["post-741","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-research-science"],"_links":{"self":[{"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/posts\/741","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/comments?post=741"}],"version-history":[{"count":2,"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/posts\/741\/revisions"}],"predecessor-version":[{"id":2679,"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/posts\/741\/revisions\/2679"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/media\/221"}],"wp:attachment":[{"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/media?parent=741"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/categories?post=741"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.durhampeptides.ca\/fr\/wp-json\/wp\/v2\/tags?post=741"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}